Markets
markets
Luke Kawa

Interactive Brokers sees a “relative return to normalcy” after last week’s meme stock buying binge

Last week’s trading activity was dominated by a retail rush to crown a host of different companies as meme stocks.

From Opendoor Technologies, which traded a whopping 1.9 billion shares on Monday, to American Eagle’s stock surging thanks to an ad campaign featuring Sydney Sweeney, the desire to speculate has been in full swing.

Looking at trading activity on Interactive Brokers’ platform over the past five sessions, the company’s chief strategist, Steve Sosnick, sees signs that this speculative wave is breaking.

“If last week’s report displayed a notable rise in speculative behavior among IBKR’s clients, then this week’s shows a relative return to normalcy,” he wrote in a discussion of the top 25 most active tickers on the platform. “While there are still several highly speculative stocks on the list — including a stock too small to have listed options — there is a return to a more normal mix of names.”

He observed that four stocks in the top 25 — Advanced Micro Devices, Oklo, Hims & Hers, and Super Micro Computer — actually saw net selling activity, “a relatively high number by recent historical standards.”

Nevertheless, Opendoor remains in the top five most active symbols and continues to see net buying, Interactive Brokers’ data shows. However, Rigetti Computing, QuantumScape, and Rocket Lab have all dropped out of the top 25 list.

More Markets

See all Markets
markets

Broadcom soars on Google’s plans for up to $185 billion in capex this year

Google’s capex guidance is Broadcom’s earnings guidance.

The hyperscaler and search giant said its 2026 capex budget would be between $175 billion and $185 billion, 55% higher than Wall Street had anticipated.

Accordingly, shares of the custom chip specialist are soaring in after-hours trading.

Broadcom has enjoyed a halo effect from Google’s capex plans and the success of its Gemini 3 model (trained on TPUs the two companies codesigned) over the past year.

But the custom chip designer had tumbled after its most recent earnings report, with some analysts attributing the decline to the dearth of new customer announcements. But who needs new customers when your current ones are opening their wallets this much?!?

Accordingly, shares of the custom chip specialist are soaring in after-hours trading.

Broadcom has enjoyed a halo effect from Google’s capex plans and the success of its Gemini 3 model (trained on TPUs the two companies codesigned) over the past year.

But the custom chip designer had tumbled after its most recent earnings report, with some analysts attributing the decline to the dearth of new customer announcements. But who needs new customers when your current ones are opening their wallets this much?!?

(J. Edward Moreno/Sherwood News)

Novo and Lilly agree prices are falling — and disagree on what comes next

Novo Nordisk and Eli Lilly are cutting prices to reach more patients — with sharply different expectations about what that means for sales.

markets

Ozempic is no longer the most searched for GLP-1 in the US

Ozempic, the popular diabetes drug made by Novo Nordisk, used to be shorthand for an entire class of diabetes and weight-loss medications. Not anymore.

According to Google Trends data, as of January, more people in the US are searching for Eli Lilly’s weight-loss shot, Zepbound, than Ozempic. At the same time, interest in the word “Ozempic” now sits roughly on par with searches for “peptides,” a catchall term for a booming, loosely regulated category of experimental supplements.

The numbers hint at a cultural shift: Ozempic is no longer the only word people reach for when they think about weight-loss drugs. The market — and the vocabulary around it — is fragmenting.

This shift also reflected in sales numbers. For several quarters now, Lillys diabetes and weight-loss drugs have outsold Novos, and that gap is expected to widen this year.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.